Evidence map›Paper›PMID 24252604›Full record

ArticleActa neuropathologica communications2013

Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis.

Vilija G Jokubaitis, Melissa M Gresle, Dennis A Kemper, William Doherty, Victoria M Perreau, Tania L Cipriani, Anna Jonas, Gerry Shaw, Tanja Kuhlmann, Trevor J Kilpatrick and 1 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Disabled-2 (International journal of molecular sciences · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice.Frontiers in cell and developmental biology · 2016
    Review
  15. Article
  16. Oncoimmunology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Vilija G JokubaitisThe Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia. vilija.jokubaitis@unimelb.edu.au.
Melissa M Gresle
Dennis A Kemper
William Doherty
Victoria M Perreau
Tania L Cipriani
Anna Jonas
Gerry Shaw
Tanja Kuhlmann
Trevor J Kilpatrick
Helmut Butzkueven
Florey Institute of Neuroscience and Mental Health · AUUniversity of Melbourne · AUFlorida College · USUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuroinflammation regulates both disease pathogenesis and repair in multiple sclerosis. In early multiple sclerosis lesion development, neuroinflammation causes demyelination and axonal injury, the likely final common determinant of disability. Here we report the identification of a novel neuroinflammatory mediator, Disabled-2 (Dab2). Dab2 is an intracellular adaptor protein with previously unknown function in the central nervous system.

resultsWe report that Dab2 is up-regulated in lesional macrophages/microglia in the spinal cord in murine experimental autoimmune encephalomyelitis, a model of multiple sclerosis. We demonstrate that dab2 expression is positively correlated with experimental autoimmune encephalomyelitis disease severity during the acute disease phase. Furthermore, dab2-deficient mice have a less severe experimental autoimmune encephalomyelitis disease course and suffer less neuroinflammation and less axonal injury than their wild-type littermates. We demonstrate that dab2 expression is strongly associated with the expression of inducible nitric oxide synthase. We further demonstrate that Dab2 is expressed at the protein level by macrophages in early acute human multiple sclerosis lesions and that this correlates with axonal injury.

conclusionsTogether, these results suggest that endogenous Dab2 exacerbates central nervous system inflammation, potentially acting to up-regulate reactive oxygen species expression in macrophages and microglia, and that it is of potential pathogenic relevance in Multiple Sclerosis.

Indexed as

Adaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportAnimalsApoptosis Regulatory ProteinsEncephalomyelitis, Autoimmune, ExperimentalFemaleInterleukin-1betaMacrophagesMaleMice, Inbred C57BLMice, KnockoutMicrogliaMultiple SclerosisNeuroimmunomodulationNitric Oxide Synthase Type IISeverity of Illness IndexAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportApoptosis Regulatory ProteinsDAB2 protein, humanDab2 protein, mouseIL1B protein, mouseInterleukin-1betaNitric Oxide Synthase Type IINos2 protein, mouseTumor Suppressor Proteins

Identifiers

PMID24252604
PMCPMC3893401
OpenAlexW2164394603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.